Fidelity Investments’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.7M Buy
8,233,435
+1,148,119
+16% +$5.81M ﹤0.01% 1461
2025
Q1
$40M Buy
7,085,316
+3,161,717
+81% +$17.9M ﹤0.01% 1433
2024
Q4
$34.1M Buy
3,923,599
+3,917,026
+59,593% +$34M ﹤0.01% 1533
2024
Q3
$45.6K Buy
+6,573
New +$45.6K ﹤0.01% 3812
2024
Q1
Sell
-298,384
Closed -$439K 5390
2023
Q4
$439K Sell
298,384
-140,674
-32% -$207K ﹤0.01% 2718
2023
Q3
$408K Sell
439,058
-13,499
-3% -$12.6K ﹤0.01% 2678
2023
Q2
$570K Sell
452,557
-160,600
-26% -$202K ﹤0.01% 2615
2023
Q1
$840K Sell
613,157
-124,439
-17% -$170K ﹤0.01% 2558
2022
Q4
$1.32M Sell
737,596
-161,803
-18% -$290K ﹤0.01% 2479
2022
Q3
$2.82M Hold
899,399
﹤0.01% 2338
2022
Q2
$2.91M Sell
899,399
-1,072,827
-54% -$3.48M ﹤0.01% 2384
2022
Q1
$10M Sell
1,972,226
-290,616
-13% -$1.48M ﹤0.01% 2118
2021
Q4
$17.7M Sell
2,262,842
-237,158
-9% -$1.85M ﹤0.01% 1886
2021
Q3
$27.1M Buy
+2,500,000
New +$27.1M ﹤0.01% 1689